Skip to content

Role of Maternal Ophthalmic artery Doppler in third trimester in prediction of pre-eclampsia

Role of Maternal Ophthalmic artery Doppler at 34â??37 weeksâ?? gestation in prediction of pre-eclampsia: Prospective study from single perinatal center

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/08/036006
Enrollment
407
Registered
2021-08-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Control Intervention1: nil: nil

Sponsors

Fernandez Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 . Singleton pregnancies between 34 to 37 weeks of gestation 2. Mothers who birth at Fernandez Hospital. 3. Structurally normal fetuses.

Exclusion criteria

Exclusion criteria: 1. Multifetal pregnancies. 2. Loss to follow up. 3. Women with already established preeclampsia at the time of OAD examination 4. Gestational hypertension on treatment with tab Methyldopa. 5. Women with Ocular pathologies e.g. High Myopia( >-5.00 DS), Glaucoma ,Ophthalmic Artery occlusion or Ophthalmic artery Aneurysm. 6. Women with vasculopathies 7. Women with renal disorders causing hypertension or proteinurea.

Design outcomes

Primary

MeasureTime frame
predictive value of PSV2/PSV 1 ratio of ophthalmic artery and development of preeclampsia or related complications.Timepoint: between 34-37 weeks of gestation

Secondary

MeasureTime frame
(i) To study the correlation of PSV2/PSV 1 ratio of ophthalmic artery with Demographic characteristics e.g. â?¢ Age â?¢ Height, Weight, BMI â?¢ Parity â?¢ Medical history of chronic illness (ii) Association of OAD (PSV2/PSV1 ratio) with development of fetal growth restriction Timepoint: between 34-37 weeks of gestation

Countries

India

Contacts

Public ContactPriyanka Paradkar

Fernandez Hospital

drsuseela@gmail.com9866611856

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026